Oman vs Southern Asia: Proportion of the target population who received a 3rd dose of
Oman
99.0%
in 2024
Southern Asia
88.0%
in 2024
Oman rank
1st
Southern Asia rank
4th
Proportion of the target population who received a 3rd dose of over time
- Oman
- Southern Asia
How they compare
Oman currently reports 99.0% against 88.0% in Southern Asia, a difference of 11.0%.
That makes Oman's figure about 1.1 times Southern Asia's.
Across all 12 years both countries report, Oman has been ahead every year.
Oman ranks 1st and Southern Asia ranks 4th of 157 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Oman | Southern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.7% | 22.9% | 75.9% | Oman |
| 2020s | 98.6% | 64.2% | 34.4% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Oman or Southern Asia?
- Oman, at 99.0% against 88.0% in Southern Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Oman and Southern Asia?
- 11.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Southern Asia?
- 12 years are reported by both, from 2013 to 2024.
- How do Oman and Southern Asia rank globally for proportion of the target population who received a 3rd dose of?
- Oman ranks 1st and Southern Asia ranks 4th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.